CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVAC CureVac B.V.

盘前交易 07-23 06:55:12 EDT

3.79

+0.12

+3.27%

盘前3.79

+0.000.00%

05:19 EDT

最高3.81	最低3.58	成交量72.28万
今开3.69	昨收3.67	日振幅6.27%
总市值8.50亿	流通市值4.64亿	总股本2.24亿
成交额270.78万	换手率0.59%	流通股本1.22亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVAC","market":"US","secType":"STK","nameCN":"CureVac B.V.","latestPrice":3.79,"timestamp":1721678400000,"preClose":3.67,"halted":0,"volume":722793,"hourTrading":{"tag":"盘前","latestPrice":3.79,"preClose":3.79,"latestTime":"05:19 EDT","volume":3,"amount":11.370000000000001,"timestamp":1721726343632},"delay":0,"floatShares":122495815,"shares":224291745,"eps":-1.316051,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.12,"latestTime":"07-23 06:55:12 EDT","open":3.69,"high":3.81,"low":3.58,"amount":2707789.296798,"amplitude":0.06267,"askPrice":3.81,"askSize":97,"bidPrice":3.76,"bidSize":92,"shortable":3,"etf":0,"ttmEps":-1.316051,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721741400000},"adr":0,"listingDate":1597377600000,"adjPreClose":3.79,"preHourTrading":{"tag":"盘前","latestPrice":3.79,"preClose":3.79,"latestTime":"05:19 EDT","volume":3,"amount":11.370000000000001,"timestamp":1721726343632},"postHourTrading":{"tag":"盘后","latestPrice":3.79,"preClose":3.79,"latestTime":"17:45 EDT","volume":868,"amount":3287.3206,"timestamp":1721684708864},"volumeRatio":0.6351040559600787,"impliedVol":1.6763,"impliedVolPercentile":0.8725},"requestUrl":"/m/hq/s/CVAC","defaultTab":"news","newsList":[{"id":"2452112487","title":"Curevac N.V.盘中异动 早盘股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452112487","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452112487?lang=zh_cn&edition=full","pubTime":"2024-07-18 22:02","pubTimestamp":1721311337,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日22时02分，Curevac N.V.股票出现波动，股价快速拉升5.07%。截至发稿，该股报3.84美元/股，成交量16.0302万股，换手率0.07%，振幅5.48%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.14%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220217aefa57ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718220217aefa57ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","BK4548","CVAC"],"gpt_icon":0},{"id":"2452162089","title":"Curevac N.V.盘中异动 快速下挫5.20%报3.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452162089","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452162089?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:42","pubTimestamp":1721234569,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时42分，Curevac N.V.股票出现波动，股价大幅下跌5.20%。截至发稿，该股报3.38美元/股，成交量28.8281万股，换手率0.13%，振幅6.88%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为1.91%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718004250941f7f81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718004250941f7f81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","BK4548","CVAC"],"gpt_icon":0},{"id":"2451909459","title":"Curevac N.V.盘中异动 急速跳水5.00%报3.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451909459","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451909459?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:37","pubTimestamp":1721137048,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日21时37分，Curevac N.V.股票出现异动，股价大幅下跌5.00%。截至发稿，该股报3.42美元/股，成交量11.4398万股，换手率0.05%，振幅3.73%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.30%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213728aef9f48c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716213728aef9f48c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4139","BK4551","CVAC"],"gpt_icon":0},{"id":"2451421675","title":"Curevac N.V.盘中异动 下午盘急速上涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451421675","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451421675?lang=zh_cn&edition=full","pubTime":"2024-07-16 01:34","pubTimestamp":1721064841,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日01时34分，Curevac N.V.股票出现异动，股价急速拉升5.21%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.29%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716013401af926a19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716013401af926a19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","CVAC","BK4548","BK4139"],"gpt_icon":0},{"id":"2450819993","title":"Curevac N.V.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450819993","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450819993?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:31","pubTimestamp":1720621914,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时31分，Curevac N.V.股票出现波动，股价快速拉升5.23%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.51%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102231559681b8fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407102231559681b8fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4007","VRPX","BK4548","BK4139","CVAC"],"gpt_icon":0},{"id":"2450026846","title":"Curevac N.V.盘中异动 早盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450026846","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450026846?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:16","pubTimestamp":1720534612,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日22时16分，Curevac N.V.股票出现波动，股价大幅下跌5.08%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为1.47%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092216529681b2aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407092216529681b2aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","LGVN","BK4139","BK4551","BK4548"],"gpt_icon":0},{"id":"2449707387","title":"Curevac N.V.盘中异动 急速下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449707387","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449707387?lang=zh_cn&edition=full","pubTime":"2024-07-08 23:45","pubTimestamp":1720453514,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日23时45分，Curevac N.V.股票出现异动，股价快速跳水5.17%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.55%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708234514aef87c97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708234514aef87c97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","BK4007","BK4551","CVAC","VRPX"],"gpt_icon":0},{"id":"2449328298","title":"Curevac N.V.盘中异动 早盘急速上涨7.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449328298","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449328298?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:33","pubTimestamp":1720186382,"startTime":"0","endTime":"0","summary":"北京时间2024年07月05日21时33分，Curevac N.V.股票出现异动，股价大幅上涨7.97%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.66%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。消息层面，截至21时33分，《JMP Securities维持CureVac买入评级，维持目标价18美元》资讯为影响Curevac N.V.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213302957cb4dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240705213302957cb4dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4551","BK4548","BK4139"],"gpt_icon":0},{"id":"2448436351","title":"摩根大通证券公司：重申CureVac(CVAC.US)评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2448436351","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448436351?lang=zh_cn&edition=full","pubTime":"2024-07-04 01:43","pubTimestamp":1720028591,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：重申curevac评级，由优于大市调整至优于大市评级,目标价由18.00美元调整至18.00美元。CureVac公司简介：CureVac NV是一家总部位于德国的生物制药公司，正在开发利用信使核糖核酸的疫苗和疗法。CureVac正在与葛兰素史克合作开发第二代COVID-19疫苗。CureVac首次开发COVID-19疫苗的尝试没有足够的有效性数据，其试验于2021年10月停止。此外，CureVac还处于肿瘤、肝脏、眼部和肺部疾病的肿瘤和分子治疗的早期开发阶段。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704014540956f63d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240704014540956f63d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC"],"gpt_icon":0},{"id":"2448488080","title":"Curevac N.V.股价上涨11.23% 市值涨9357.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448488080","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448488080?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:31","pubTimestamp":1720013467,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时31分，Curevac N.V.股票出现波动，股价大幅拉升11.23%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.24%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213107956e186b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213107956e186b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4548","BK4139","BK4551"],"gpt_icon":0},{"id":"2448817360","title":"CureVac盘前大涨，向葛兰素史克卖出流感和新冠疫苗版权","url":"https://stock-news.laohu8.com/highlight/detail?id=2448817360","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448817360?lang=zh_cn&edition=full","pubTime":"2024-07-03 16:37","pubTimestamp":1719995825,"startTime":"0","endTime":"0","summary":"在这一消息提振之下，CureVac股价在美股夜盘交易时段跳涨超23%。据了解，葛兰素史克与生物科技公司CureVac的这一合作关系始于2020年全球新冠疫情期间，两家公司合作开发基于mRNA技术的传染病疫苗。葛兰素史克是世界领先的疫苗制造商之一。据了解，CureVac正在出售其主要的疫苗开发项目，接受葛兰素史克的预付款，以提高其现金流基本状况，并专注于新的癌症治疗方法。","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1144975.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","CVAC","BK4551","BK4532","BK4585","LU1829250122.USD","BK4007","BK4548","BK4139"],"gpt_icon":1},{"id":"2446165003","title":"Curevac N.V.盘中异动 股价大跌5.08%报3.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446165003","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446165003?lang=zh_cn&edition=full","pubTime":"2024-06-27 00:26","pubTimestamp":1719419189,"startTime":"0","endTime":"0","summary":"北京时间2024年06月27日00时26分，Curevac N.V.股票出现波动，股价急速下挫5.08%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.97%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002630aef6c231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627002630aef6c231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CVAC","BK4548","BK4551"],"gpt_icon":0},{"id":"2446272158","title":"Curevac N.V.盘中异动 股价大涨5.04%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446272158","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446272158?lang=zh_cn&edition=full","pubTime":"2024-06-26 02:17","pubTimestamp":1719339453,"startTime":"0","endTime":"0","summary":"北京时间2024年06月26日02时17分，Curevac N.V.股票出现异动，股价急速上涨5.04%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.35%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626021733af8f2438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240626021733af8f2438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4548","BK4551","BK4139"],"gpt_icon":0},{"id":"2445205003","title":"Curevac N.V.盘中异动 股价大涨5.21%报3.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445205003","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445205003?lang=zh_cn&edition=full","pubTime":"2024-06-24 23:02","pubTimestamp":1719241326,"startTime":"0","endTime":"0","summary":"北京时间2024年06月24日23时02分，Curevac N.V.股票出现异动，股价大幅上涨5.21%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.37%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624230206941f0993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240624230206941f0993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4139","BK4551","BK4548"],"gpt_icon":0},{"id":"2444116385","title":"Curevac N.V.盘中异动 股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2444116385","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444116385?lang=zh_cn&edition=full","pubTime":"2024-06-18 03:05","pubTimestamp":1718651126,"startTime":"0","endTime":"0","summary":"北京时间2024年06月18日03时05分，Curevac N.V.股票出现异动，股价快速跳水5.45%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.19%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618030526aef54d02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240618030526aef54d02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","CVAC","BK4139","BK4548"],"gpt_icon":0},{"id":"2443620031","title":"Curevac N.V.盘中异动 早盘股价大跌5.80%报3.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443620031","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443620031?lang=zh_cn&edition=full","pubTime":"2024-06-14 21:30","pubTimestamp":1718371849,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日21时30分，Curevac N.V.股票出现波动，股价急速下挫5.80%。截至发稿，该股报3.77美元/股，成交量2.8973万股，换手率0.01%，振幅0.25%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.32%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614213049af8da1be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614213049af8da1be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4551","LGVN","BK4548","CVAC"],"gpt_icon":0},{"id":"2443963169","title":"Curevac N.V.盘中异动 股价大跌5.06%报3.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2443963169","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2443963169?lang=zh_cn&edition=full","pubTime":"2024-06-14 01:37","pubTimestamp":1718300225,"startTime":"0","endTime":"0","summary":"北京时间2024年06月14日01时37分，Curevac N.V.股票出现异动，股价快速跳水5.06%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.19%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614013705af8d71da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240614013705af8d71da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4139","BK4551","LGVN","CVAC"],"gpt_icon":0},{"id":"2442355446","title":"Curevac N.V.盘中异动 早盘股价大涨5.41%报4.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2442355446","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442355446?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:32","pubTimestamp":1718199127,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时32分，Curevac N.V.股票出现异动，股价大幅拉升5.41%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.39%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221320896813b1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061221320896813b1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4548","BK4551","BK4139"],"gpt_icon":0},{"id":"2442917413","title":"Curevac N.V.盘中异动 早盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442917413","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2442917413?lang=zh_cn&edition=full","pubTime":"2024-06-11 21:33","pubTimestamp":1718112831,"startTime":"0","endTime":"0","summary":"北京时间2024年06月11日21时33分，Curevac N.V.股票出现异动，股价快速下跌5.01%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.37%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611213351af8cf458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240611213351af8cf458&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4551","BK4548","BK4139"],"gpt_icon":0},{"id":"2441066472","title":"Curevac N.V.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441066472","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441066472?lang=zh_cn&edition=full","pubTime":"2024-06-07 21:35","pubTimestamp":1717767309,"startTime":"0","endTime":"0","summary":"北京时间2024年06月07日21时35分，Curevac N.V.股票出现波动，股价快速下挫5.21%。Curevac N.V.股票所在的生物技术行业中，整体跌幅为0.02%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。CureVac正在与GSK合作开发第二代新冠疫苗。CureVac最初尝试开发新冠疫苗并未获得足够的有效性数据，其试验在2021年10月停止。此外，CureVac正处于早期阶段，开发用于肿瘤、肝脏、眼睛和肺部疾病的肿瘤学和分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607213509aef410db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240607213509aef410db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4548","BK4551","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.curevac.com","stockEarnings":[{"period":"1week","weight":0.0528},{"period":"1month","weight":0.1626},{"period":"3month","weight":0.4577},{"period":"6month","weight":0.0528},{"period":"1year","weight":-0.5964},{"period":"ytd","weight":-0.0998}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Curevac N.V.于2020年4月7日根据荷兰法律注册成立。该公司是一家全球性的临床阶段生物制药公司，开发基于信使核糖核酸的新型转化药物，该药物具有改善人们生活的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.074507},{"month":2,"riseRate":0.25,"avgChangeRate":-0.078931},{"month":3,"riseRate":0.25,"avgChangeRate":-0.042891},{"month":4,"riseRate":0.5,"avgChangeRate":0.009789},{"month":5,"riseRate":0.75,"avgChangeRate":0.226595},{"month":6,"riseRate":0.25,"avgChangeRate":-0.165776},{"month":7,"riseRate":0.25,"avgChangeRate":-0.092283},{"month":8,"riseRate":0.333333,"avgChangeRate":0.018529},{"month":9,"riseRate":0,"avgChangeRate":-0.189876},{"month":10,"riseRate":0.25,"avgChangeRate":-0.129659},{"month":11,"riseRate":0.75,"avgChangeRate":0.343537},{"month":12,"riseRate":0,"avgChangeRate":-0.226567}],"exchange":"NASDAQ","name":"CureVac B.V.","nameEN":"CureVac B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CureVac B.V.,CVAC,CureVac B.V.股票,CureVac B.V.股票老虎,CureVac B.V.股票老虎国际,CureVac B.V.行情,CureVac B.V.股票行情,CureVac B.V.股价,CureVac B.V.股市,CureVac B.V.股票价格,CureVac B.V.股票交易,CureVac B.V.股票购买,CureVac B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}